Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion

Nitric Oxide - Biology and Chemistry

Volumn 21, Issue 1, 2009, Pages 27-36

  Nilforoushan, Dorrin ^a   Gramoun, Azza ^a   Glogauer, Michael ^b   Manolson, Morris F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CIHR Group In Matrix Dynamics   (Canada)

Author keywords

Fusion; Nitric oxide; Osteoclast; Osteoclastogenesis; Pre osteoclast

Indexed keywords

4,5 DIAMINOFLUORESCEIN DIACETATE; ACTIN; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POLYSTYRENE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; MICROPHOTOGRAPHY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ACID PHOSPHATASE; ACTINS; ANALYSIS OF VARIANCE; ANIMALS; CELL DIFFERENTIATION; CELL FUSION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME INHIBITORS; ISOENZYMES; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRITES; NITROSO COMPOUNDS; OMEGA-N-METHYLARGININE; OSTEOCLASTS; PHOTOMICROGRAPHY; POLYLYSINE; RABBITS;

EID: 67649804650     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2009.04.002     Document Type: Article

References (42)

1. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
2. Lamas S., Michel T., Brenner B.M., and Marsden P.A. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha. Am. J. Physiol. 261 (1991) C634-C641
3. Lamas S., Michel T., Collins T., Brenner B.M., and Marsden P.A. Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J. Clin. Invest. 90 (1992) 879-887
4. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., De Montellano P.R., Kemp B.E., and Pearson R.B. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9 (1999) 845-848
5. Uematsu M., Ohara Y., Navas J.P., Nishida K., Murphy T.J., Alexander R.W., Nerem R.M., and Harrison D.G. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am. J. Physiol. 269 (1995) C1371-C1378
6. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
7. Kartsogiannis V., and Ng K.W. Cell lines and primary cell cultures in the study of bone cell biology. Mol. Cell Endocrinol. 228 (2004) 79-102
8. Ralston S.H., Ho L.P., Helfrich M.H., Grabowski P.S., Johnston P.W., and Benjamin N. Nitric oxide: a cytokine-induced regulator of bone resorption. J. Bone Miner. Res. 10 (1995) 1040-1049
9. Dong S.S., Williams J.P., Jordan S.E., Cornwell T., and Blair H.C. Nitric oxide regulation of cGMP production in osteoclasts. J. Cell Biochem. 73 (1999) 478-487
10. Yaroslavskiy B.B., Li Y., Ferguson D.J., Kalla S.E., Oakley J.I., and Blair H.C. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J. Cell Biochem. 91 (2004) 962-972
11. Holliday L.S., Dean A.D., Lin R.H., Greenwald J.E., and Gluck S.L. Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am. J. Physiol. 272 (1997) F283-F291
12. Collin-Osdoby P., Rothe L., Bekker S., Anderson F., and Osdoby P. Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. J. Bone Miner. Res. 15 (2000) 474-488
13. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., and Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351 (1991) 714-718
14. Robinson L.J., Weremowicz S., Morton C.C., and Michel T. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics 19 (1994) 350-357
15. Lowenstein C.J., Glatt C.S., Bredt D.S., and Snyder S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89 (1992) 6711-6715
16. van't Hof R.J., Macphee J., Libouban H., Helfrich M.H., and Ralston S.H. Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 145 (2004) 5068-5074
17. Aguirre J., Buttery L., O'Shaughnessy M., Afzal F., Fernandez I., de Marticorena M., Hukkanen P., Huang I., MacIntyre J., and Polak J. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am. J. Pathol. 158 (2001) 247-257
18. Cuzzocrea S., Mazzon E., Dugo L., Genovese T., Di Paola R., Ruggeri Z., Vegeto E., Caputi A.P., Van De Loo F.A., Puzzolo D., and Maggi A. Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology 144 (2003) 1098-1107
19. Lee K.H., Baek M.Y., Moon K.Y., Song W.K., Chung C.H., Ha D.B., and Kang M.S. Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269 (1994) 14371-14374
20. Manolson M.F., Yu H., Chen W., Yao Y., Li K., Lees R.L., and Heersche J.N. The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large (≥10 nuclei) and small (≤ nuclei) osteoclasts. J. Biol. Chem. 278 (2003) 49271-49278
21. Hsu H., Lacey D.L., Dunstan C.R., Solovyev I., Colombero A., Timms E., Tan H.L., Elliott G., Kelley M.J., Sarosi I., Wang L., Xia X.Z., Elliott R., Chiu L., Black T., Scully S., Capparelli C., Morony S., Shimamoto G., Bass M.B., and Boyle W.J. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96 (1999) 3540-3545
22. Lees R.L., and Heersche J.N. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size. J. Bone Miner. Res. 14 (1999) 937-945
23. Trebec D.P., Chandra D., Gramoun A., Li K., Heersche J.N., and Manolson M.F. Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases. J. Cell Biochem. 101 (2007) 205-220
24. Wu G.Y., and Brosnan J.T. Macrophages can convert citrulline into arginine. Biochem. J. 281 Pt 1 (1992) 45-48
25. Voronov I., Heersche J.N., Casper R.F., Tenenbaum H.C., and Manolson M.F. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration. Biochem. Pharmacol. 70 (2005) 300-307
26. Amin M., Ho A.C., Lin J.Y., Batista da Silva A.P., Glogauer M., and Ellen R.P. Induction of de novo subcortical actin filament assembly by Treponema denticola major outer sheath protein. Infect. Immun. 72 (2004) 3650-3654
27. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70 (1998) 2446-2453
28. Kojima H., Sakurai K., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., and Nagano T. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem. Pharm. Bull (Tokyo) 46 (1998) 373-375
29. Kikkawa I., Saito S., Tominaga K., Hoshino Y., Ooi Y., and Nakano M. Lipopolysaccharide (LPS) stimulates the production of tumor necrosis factor (TNF)-alpha and expression of inducible nitric oxide synthase (iNOS) by osteoclasts (OCL) in murine bone marrow cell culture. Microbiol. Immunol. 42 (1998) 591-598
30. Luo L., Cruz T., and McCulloch C. Interleukin 1-induced calcium signalling in chondrocytes requires focal adhesions. Biochem. J. 324 Pt. 2 (1997) 653-658
31. Goldberg S., Doyle R.J., and Rosenberg M. Mechanism of enhancement of microbial cell hydrophobicity by cationic polymers. J. Bacteriol. 172 (1990) 5650-5654
32. Chen E.H., and Olson E.N. Unveiling the mechanisms of cell-cell fusion. Science 308 (2005) 369-373
33. Bear J.E., Svitkina T.M., Krause M., Schafer D.A., Loureiro J.J., Strasser G.A., Maly I.V., Chaga O.Y., Cooper J.A., Borisy G.G., and Gertler F.B. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 109 (2002) 509-521
34. Hartwig J.H., Bokoch G.M., Carpenter C.L., Janmey P.A., Taylor L.A., Toker A., and Stossel T.P. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82 (1995) 643-653
35. Olken N.M., and Marletta M.A. NG-methyl-l-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry 32 (1993) 9677-9685
36. Abu-Soud H.M., Feldman P.L., Clark P., and Stuehr D.J. Electron transfer in the nitric-oxide synthases, characterization of l-arginine analogs that block heme iron reduction. J. Biol. Chem. 269 (1994) 32318-32326
37. Zheng H., Yu X., Collin-Osdoby P., and Osdoby P. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption. J. Biol. Chem. 281 (2006) 15809-15820
38. Nicolin V., Ponti C., Narducci P., Grill V., Bortul R., Zweyer M., Vaccarezza M., and Zauli G. Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 286 (2005) 945-954
39. McLaughlin L.M., and Demple B. Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53. Cancer Res. 65 (2005) 6097-6104
40. Fan X., Roy E., Zhu L., Murphy T.C., Ackert-Bicknell C., Hart C.M., Rosen C., Nanes M.S., and Rubin J. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology 145 (2004) 751-759
41. Lohse M.J., Forstermann U., and Schmidt H.H. Pharmacology of NO:cGMP signal transduction. Naunyn Schmiedebergs Arch. Pharmacol. 358 (1998) 111-112
42. Barzik M., Kotova T.I., Higgs H.N., Hazelwood L., Hanein D., Gertler F.B., and Schafer D.A. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J. Biol. Chem. 280 (2005) 28653-28662